The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The top analyst upgrades, downgrades and other research calls from Friday include AIG, Expedia, FireEye, Nvidia, 3D Systems, Teva Pharmaceutical, Twitter, Disney, Wayfair and Wynn Resorts.
The January 12 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The December 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Judging by the most shorted stocks traded on the New York Stock Exchange, short sellers were mostly ready to lighten up on those stocks between the December 15 and December 29 settlement…
The top analyst upgrades, downgrades and other research calls from Tuesday include AK Steel, Carnival, FedEx, PayPal, Sunoco, Teva Pharmaceutical, Under Armour and Wells Fargo.
Alder Biopharmaceuticals saw its shares make a solid gain on Monday amid a blizzard of updates from the company.
Chris Lange Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves in 2018.
The top analyst upgrades, downgrades and other research calls from Friday include Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva Pharmaceuticals, Tyson Foods, Walgreens Boots Alliance.
The December 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Teva Pharmaceutical saw its shares make a small gain on Wednesday after the firm announced the exclusive launch of a generic version of Reyataz capsules in the United States.
Chris Lange Teva Pharmaceutical Industries kicked off the week by announced an FDA for its treatment for migraines.
Chris Lange Another company has decided that the best time to fire a large number of people is just before the holidays.
Douglas A. McIntyre The FCC has killed net neutrality, Disney has become the king of all media, holiday spending has been unusually strong, and more important headlines.
Teva Pharmaceutical Industries shares turned south on Wednesday after the company said that it would be announcing its restructuring plan on Thursday.
Chris Lange 
